Blockchain

INX and Backed Launch On-Chain Tokenized NVIDIA Stock Trading

Zug, Switzerland, July 2nd, 2024, Chainwire

INX, the regulated marketplace for trading security tokens and tokenized real-world assets, and Backed, a pioneer in real-world asset tokenization, today announced the listing of tokenized stock on the INX platform for eligible non-US users. This groundbreaking partnership begins with the launch of bNVDA, a tokenized security backed one-to-one by NVIDIA Corp (NVDA) stock, issued on the Ethereum network, with the blockchain ledger conveying ownership.

The Future of Investing

This launch is a monumental step towards democratizing access to traditional financial assets and merging them with the 24/7 liquidity and accessibility of the digital asset space. Non-US eligible investors will be able to trade bNVDA with the ease and speed of cryptocurrencies, outside of traditional stock market hours, and with the ability to fund their account with crypto. Self-custodial securities open up new possibilities for traders. This is only the start, with more assets coming in the pipeline, such as ETFs, Bonds, or even commodities arriving on INX in the future. Backed’s tokenized public securities are called bTokens, which are permissionless ERC-20 tokens that can be transferred between wallets freely.

“We are thrilled to have Backed as one of our tokenization and issuance partners, and we’re excited to initiate the listing of their securities in our marketplace.” said Shy Datika, CEO of INX. “This partnership represents another milestone in our journey to enable the trading of real-world assets tokens. We are committed to advancing the accessibility and efficiency of the tokenized asset market, ushering in a new era of global finance.”

Adam Levi, Backed Co-Founder, added, “Crypto traders have been seeking a seamless bridge to the traditional market – and tokenized stocks provide exactly that. bNVDA is just the beginning; we envision a future where investors can build diversified portfolios of tokenized real-world assets directly on the blockchain. No need to offramp, and users can self custody their entire portfolio.”

INX provides a marketplace for tokenized assets and their partnership with Backed brings the first tokenized share to this market. This means that Backed’s bNVDA can now be traded on INX, which integrates crypto, fiat, and security tokens into a unified marketplace. Traders can now benefit from 24/7 availability to trade bNVDA, and fractional share ownership.

Backed’s tokenized assets, including bNVDA, are issued under an EU prospectus, allowing eligible investors to have full transparency of the products. Holders of bNVDA have the primary claim to the collateral value, in this case, Nvidia stock, which is held with a licensed custodian under an account control agreement. Distributed ledgers (blockchains) are the primary way that ownership is defined.

With Republic recently reaffirming its commitment to form a strong partnership with INX, and Backed completing their Series A funding round, the ecosystem for tokenized securities is becoming increasingly exciting. With partnerships like this, true interoperability and composability is becoming a reality.

Key Benefits:

●     Self-Custody: Hold the securities directly in a wallet that only you have control over.

●     24/7 Trading: Trade anytime, anywhere, not limited by traditional market hours.

●     DeFi ready: Use your tokenized stocks as collateral for loans or within other DeFi applications.

●     Blockchain Security: Leverage the inherent security and transparency of blockchain technology.

●     Access: Available to non-US qualified investors across multiple jurisdictions.

●     All On-chain: Fund your account with crypto and invest in tokenized stocks.

How to Get Started

Right now, to trade bNVDA, investors need to create an account on the INX platform and complete the required verification process.

About INX

INX provides regulated trading platforms for digital securities and cryptocurrencies. With the combination of traditional markets expertise and a disruptive fintech approach, INX provides state-of-the-art solutions to modern financial problems. INX is led by an experienced and dedicated team of business, finance, and technology veterans with the shared vision of redefining the world of capital markets via blockchain technology and a disciplined regulatory approach

In a world where anything can be tokenized on a blockchain network, INX provides an innovative, regulated marketplace for trading these security tokens, accommodating both fiat and cryptocurrencies. Led by an experienced and dedicated team of business, finance, and technology veterans, INX shares a vision to redefine capital markets through blockchain technology and a disciplined regulatory approach.

LinkedIn: https://www.linkedin.com/company/theinxdigitalcompany/

X / Twitter: https://x.com/INX_Group

Website: https://www.inx.co/

About Backed

Backed brings real-world assets on-chain. Backed issues permissionless tokens that track the value of real-world assets and are fully collateralized by them, such as stocks or ETFs. Tokens are issued under an approved EU prospectus. Backed offers tokenization services to institutional clients, bridging the gap between TradFi and DeFi.

The Backed Assets (JE) bNVDA (ticker symbol: bNVDA) is a tracker certificate issued as an ERC-20 token, which tracks the price of the NVIDIA Corp.

Backed’s tracker products (bTokens) are not offered, sold, or delivered within the United States, or for the account or benefit of U.S. Persons. For a full list of prohibited and restricted countries, and to review legal documentation, please visit https://www.assets.backed.fi/legal-documentation

LinkedIn: https://www.linkedin.com/company/backed-finance/

X / Twitter: https://twitter.com/backedfi

Website: https://backed.fi/

 

 

 

 

Contact

MarketAcross
[email protected]

PostAd_coinrule_banner728x90

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Keiretsu Forum Announces Dr. Martin Gershon as Keynote Speaker for 2024 Investor Capital Expo

2024-10-02T11:08:00Z

PHILADELPHIA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Keiretsu Forum, the world's largest and most active accredited angel investor network, is proud to announce that Dr. Martin Gershon, a prominent leader in healthcare innovation and venture capital, will deliver the keynote address at the 2024 Investor Capital Expo. This signature event in early-stage investment community will be held on October 31, 2024, at Convene City View in Philadelphia.

Dr. Gershon, Managing Partner and Chief Investment Officer of Endeavor Venture Funds and Endeavor Venture Studio, brings over two decades of experience in life sciences and healthcare startups. His leadership at Endeavor has resulted in over 100 investments and 24 successful exits, solidifying his reputation as a strategic force in healthcare investment. Under his guidance, Endeavor Venture Funds has become synonymous with cutting-edge innovation, most recently, in artificial intelligence (AI)-powered drug discovery.

Recognized as a "Top Voice" in Venture Capital and Entrepreneurship by LinkedIn and named a Top 100 Healthcare Industry Leader by Standard & Poor’s, Dr. Gershon is a sought-after advisor and speaker. His keynote, titled "Pioneering Healthcare Innovation: Investment Strategies in AI Drug Discovery," will delve into the transformative impact of AI on the drug development process. His address will focus on:

  • Investment Opportunities: Exploring high-growth potential in AI-driven drug discovery.
  • Strategic Insights: Understanding how AI is accelerating the development of novel therapeutics.
  • Future Trends: Highlighting upcoming innovations that will shape the life sciences and healthcare sectors.

Keiretsu Forum: A Global Leader in Early-Stage Innovation

Keiretsu Forum continues to be a global leader in early-stage innovation, offering unparalleled access to groundbreaking companies across industries. The Investor Capital Expo serves as the premier gathering for angel investors, venture capitalists, family offices, and entrepreneurs, spotlighting companies that have undergone Keiretsu Forum's rigorous due diligence process. The event provides an invaluable platform for investors to engage with high-potential startups, network with peers, and gain insights from leading industry experts.

Keiretsu Forum has a relationship with Endeavor and Dr Gershon that has at its core aligned vision and lays the solid platform for access to a larger number of remarkable Founder Entrepreneurs and strategic partnerships with the Endeavor investor ecosystem for follow on rounds and sustained growth.

"Dr. Gershon's expertise in healthcare and AI makes him an ideal keynote speaker for this year’s Expo," said Howard Lubert, Regional President of Keiretsu Forum. "His contributions to the commercialization of life-saving technologies and his leadership in AI innovation exemplify the type of visionary thinking that drives the success of early-stage ventures."

Event Details

  • Date: October 31, 2024
  • Time: 8:00 AM – 6:00 PM EDT
  • Location: Convene City View, 30 S 17th St, Philadelphia, PA

Accredited angel investors are encouraged to register for this exclusive event, where they can engage with the next wave of industry disruptors and gain key insights from one of healthcare’s leading innovators.

About Keiretsu Forum :

Keiretsu Forum is the world’s largest private equity angel investment network with 2000+ accredited investors in 35 North American and 23 International chapters, who have invested more than $1B in early-stage companies in the last 23 years.

The Keiretsu Forum portfolio features Entrepreneurs and Companies from Technology-(Internet, Software, Cyber Security, SaaS, Mobile Systems, IoT, etc.), Life Sciences-(Pharma, Medical Devices, Health IT, etc.), FinServ/FinTech, Consumer Products, Clean-Green Energy, Consumer Products, & more!

About Dr. Martin Gershon

Dr. Gershon's career has been marked by his pioneering efforts in healthcare and life sciences innovation. His role at Endeavor Venture Funds connects emerging companies with Fortune 500 partnerships, offering strategic growth solutions and regulatory expertise. Dr. Gershon has advised numerous organizations, including the White House Moonshot CancerX Accelerator, Goldman Sachs, and Bain Capital.

Dr. Gershon’s academic credentials are equally impressive, with advanced training in neuroscience, oncology, and immunology from Harvard, McGill, and Columbia. He has also served as an FDA attorney and has been honored as a Google Scholar in Entrepreneurship.

For media inquiries, please contact:

Cindi Sutera
AMS Communications
[email protected]
610-613-2773


GlobeNewsWire News

Recent Comments